Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: A microdialysis study in rats

Journal of Neural Transmission

Volumn 106, Issue 9-10, 1999, Pages 803-818

  Hesselink, M B ^a,b   De Boer, A G ^b   Breimer, D D ^b   Danysz, W ^a  

^a MERZ PHARMACEUTICALS GMBH   (Germany)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Dopamine; Memantine; Microdialysis; Pharmacokinetics; Prefrontal cortex

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; LEARNING; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; HOMOVANILLIC ACID; MALE; MEMANTINE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032720258     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050201     Document Type: Article

References (27)

1. Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229: 75-82
2. Chapman CD, Gazzara RA, Howard SG (1990) Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats. Neuropharmacology 29: 319-325
3. Clement HW, Grote C, Svensson L, Engel J, Zofel P, Wesemann W (1995) In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat. J Neural Transm [Suppl] 46: 107-115
4. Danysz W, Gossel M, Zajaczkowski W, Dill D, Quack G (1994) Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? case of amantadine and memantine. J Neural Transm [PD-Sect] 7: 155-166
5. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 21: 455-468
6. Ditzler K (1991) Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneimittelforschung 8: 773-780
7. French ED, Ceci A (1990) Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tagmental A10 dopamine neurons. Neurosci Lett 119: 159-162
8. French ED, Mura A, Ting W (1993) MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat a 10-dopamine neurons - comparison to competitive NMDA antagonists. Synapse 13: 108-116
9. Goff DC, Wine L (1997) Glutamate in schizophrenia: clinical and research implications. Schizophr Res 27: 157-168
10. Hesselink MB, de Boer AG, Breimer DD, Danysz W (1999a) Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study. Pharm Res 16: 637-642
11. Hesselink MB, Smolders H, De Boer AG, Breimer DD, Danysz W (1999b) Modifications of the behavioural profile of uncompetitive NMDA receptor antagonist, memantine, amantadine and (+)MK-801 after chronic administration. Behav Pharmacol 10: 85-98
12. Kalivas PW (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37: 95-100
13. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166: 589-590
14. Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm 43 [Suppl]: 91-104
15. Lindefors N, Barati S, O'Connor WT (1997) Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Res 759: 205-212
16. Misztal M, Frankiewicz T, Parsons CG, Danysz W (1996) Learning deficits induced by chronic intraventricular infusion of quinolinic acid - protection by MK-801 and memantine. Eur J Pharmacol 296: 1-8
17. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927
18. Nishijima K, Kashiwa A, Hashimoto A, Iwama H, Umino A, Nishikawa T (1996) Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and stratum as revealed by in vivo dialysis. Synapse 22: 304-312
19. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (l-amino-3,5-dimethyladamantan). Neuropharmacology 32: 1337-1350
20. Parsons CG, Danysz W, Quack G (1998) Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 11: 523-569
21. Quack G, Hesselink M, Danysz W, Spanagel R (1995) Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover. J Neural Transm 46 [Suppl]: 97-105
22. Schmidt CJ, Fadayel GM (1996) Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2a receptor blockade. J Pharmacol Exp Ther 277: 1541-1549
23. Seutin V, Verbanck P, Massotte L, Dresse A (1990) Evidence for the presence of N-methyl-D-aspartate receptors in the ventral tegmental area of the rat - an electrophysiological in vitro study. Brain Res 514: 147-150
24. Spanagel R, Eilbacher B, Wilke R (1994) Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur J Pharmacol 262: 21-26
25. Tarazi FI, Florijn WJ, Creese I (1996) Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128: 371-379
26. Ulas J, Nguyen L, Cotman CW (1993) Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport 4: 1049-1051
27. Wedzony K, Golembiowska K, Zazula M (1994) Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn Schmiedebergs Arch Pharmacol 350: 555-562